Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation for promoting stability of ceftriaxone sodium granules

A ceftriaxone sodium and stabilizer technology, which is applied in the field of ceftriaxone sodium granules, can solve the problems of poor sensitivity and achieve the effects of simple operation, improved appearance and storage time, and cost saving

Inactive Publication Date: 2011-04-27
TIANJIN PACIFIC PHARMA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Enterobacter cloacae, Acinetobacter spp and Pseudomonas aeruginosa have poor susceptibility to the drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation for promoting stability of ceftriaxone sodium granules

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0020] Ceftriaxone Sodium 0.3g

[0021] Glucose 3.5g

[0022] Mannitol 5.5g

[0023] Aspartame 0.2g

[0024] Sodium metabisulfite 0.005g

[0025] Flavor 0.05g

example 2

[0027] Ceftriaxone Sodium 0.3g

[0028] Lactose 4.5g

[0029] Sucrose 5.0g

[0030] Aspartame 0.1g

[0031] Thiourea 0.01g

[0032] Flavor 0.1g

example 3

[0034] Ceftriaxone Sodium 0.5g

[0035] Glucose 1.7g

[0036] Mannitol 4.6g

[0037] Aspartame 0.1g

[0038] Sodium bisulfite (potassium) 0.03g

[0039] Flavor 0.05g

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation for promoting the stability of ceftriaxone sodium granules, which consists of ceftriaxone sodium serving as an active ingredient, a stabilizer and pharmaceutically acceptable soluble auxiliary materials according to a weight ratio of 1: 0.01-1: 15-50, preferably 1: 0.05-0.2: 15-30. The medicament composition prepared by the invention avoids the unstable phenomenon that the chemical reaction of ceftriaxone sodium and monosaccharide or polysaccharide, in particular lactose, which are mixed, is performed to produce brown blocks; and operation is simple and convenient, cost is saved, and the medicament composition is more suitable for mass industrial production.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, in particular to a granule of ceftriaxone sodium. Background technique [0002] Ceftriaxone Sodium (Rocephin) is a third-generation cephalosporin antibiotic, used for lower respiratory tract infection, urinary tract, biliary tract infection caused by sensitive pathogenic bacteria, as well as abdominal infection, pelvic infection, skin and soft tissue infection, Bone and joint infection, sepsis, meningitis, etc. and infection prevention during surgery. Similar drugs include ceftriaxone, ceftriaxone, junbizhi, thiatriazine, cephalosporins, ceftaxone, etc. Strong activity against Enterobacteriaceae bacteria. The MIC90 for Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Citrobacter freundii, indole-positive Proteus, Pruvidenella and Serratia is between 0.12 and 0.25mg / Between L. Enterobacter cloacae, Acinetobacter and Pseudomonas aeruginosa were less sensitive to the d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/02A61K47/20A61K9/16A61K31/546A61P31/04
Inventor 宋德成高永清宁德科郎琳王磊
Owner TIANJIN PACIFIC PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products